American Portfolios Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

American Portfolios Advisors’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,000	Closed	-$9K	–	2983
2019 Q3	$9K	Sell	2,000 -542	-21%	-$2.71K	﹤0.01%	1971
2019 Q2	$12.1K	Hold	2,542	–	–	﹤0.01%	1844
2019 Q1	$13.9K	Buy	+2,542	New	+$11.7K	﹤0.01%	1710
2018 Q4	–	Sell	-8,615	Closed	-$36.1K	–	2641
2018 Q3	$36.1K	Hold	8,615	–	–	﹤0.01%	1253
2018 Q2	$33.3K	Hold	8,615	–	–	﹤0.01%	1244
2018 Q1	$54.6K	Buy	8,615 +2,624	+44%	+$21.7K	0.01%	979
2017 Q4	$48.3K	Buy	+5,991	New	+$55.9K	0.01%	1009

Other funds holding MACK

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $1.99B AUM 22.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WIM

Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

American Portfolios Advisors's MACK Position: Q4 2019 in Review

American Portfolios Advisors sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2019, closing a stake of 2,000 shares — an estimated $9K sold.

American Portfolios Advisors first reported a position in MACK in Q4 2017 and held it in 7 quarters. The position peaked at $54.6K in Q1 2018. 48 funds tracked by Wall St. Rank hold MACK as of Q4 2019.

American Portfolios Advisors reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
American Portfolios Advisors sold 2,000 Merrimack Pharmaceuticals, Inc. shares in Q4 2019, an estimated $9K.
American Portfolios Advisors first reported a position in Merrimack Pharmaceuticals, Inc. in Q4 2017 and held it in 7 quarters.
American Portfolios Advisors's Merrimack Pharmaceuticals, Inc. position peaked at $54.6K in Q1 2018.
48 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2019.

Based on American Portfolios Advisors's 13F filing for Q4 2019, filed 24 Mar 2023.